profit from every $100 of sales.
$0$100
BGM Group
$7.70-3.87% today
-97.3% in 1 year
1-year low $7.201-year high $287.10
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What BGM Group sold, what it kept, and what it did with the cash.
Sales went from $57.1 million in 2021 to $25.1 million in 2024, with -$1.44 million of profit last year.
SalesProfit
BGM Group vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| BGM Group | No profit yet | ||
 Merck KGaA | 24.8× · Fair price | ||
 Takeda Pharmaceutical | 101.0× · Very expensive | ||
 Galderma Group | 88.6× · Very expensive | ||
 Teva Pharmaceutical Industries | 36.1× · Expensive |
AI analysis
An AI analyst reads BGM Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 57 | 65 | 46 | 25 | |
| 6 | 6 | 2 | 4 | |
| 3 | 3 | -2 | -0 | |
| 4 | 4 | -1 | 1 | |
| 3 | 1 | -8 | -1 | |
| 0.45 | 0.15 | -1.08 | -0.20 | |
| 9.9% | 9.6% | 3.8% | 16.4% | |
| 5.2% | 3.9% | -5.2% | -1.4% | |
| 5.5% | 1.7% | -16.7% | -5.7% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 75 | 65 | 51 | 53 |
| Cash | 10 | 14 | 7 | 10 |
| Total debt | 8 | 2 | 1 | 0 |
| Total liabilities | 19 | 10 | 7 | 9 |
| 55 | 53 | 43 | 43 | |
| 7 | 7 | 7 | 7 | |
| 3.7% | 3.6% | -4.4% | -0.7% | |
| 5.7% | 2.0% | -18.2% | -3.4% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 0 | 13 | 0 | 1 | |
| 3 | 3 | 4 | 4 | |
| -3 | 9 | -3 | -3 | |
| Dividends paid | – | 0 | 2 | 0 |
| – | – | – | – | |
| 0 | 0 | 0 | 0 |
Valuation
- –
- –
- –
- 0.0×
- 4.1×
- –
- 105.7×
- -3.3%
- -1.4%
- 0.0%
Profitability
- 16.4%
- -1.4%
- -5.7%
- 3.5%
- -0.9%
- 0.1%
- -3.4%
- -2.7%
- -1.3%
- 5.4%
Growth
- −24.0%
- –
- +0.4%
- –
- +0.8%
Financial health
- -11.2×
- 0.00
- 0.0%
- -0.9×
- 3.39
- 2.82
- 0.47
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 34%of 952
Bottom 19%of 883
Bottom 4%of 870
Bottom 24%of 985
News
SBC Medical Group Holdings GAAP EPS of $0.15 beats by $0.03, revenue of $59M beats by $10.11MSeeking Alpha · Nov 13, 2026Nebius Group (NBIS) Takes a Beating — This Tech Giant Is to BlameYahoo Finance · Nov 13, 2026Nebius Group (NBIS) Gets Gartner Backing Through A $13 Million AI Platform WinYahoo Finance · Nov 12, 2026What Nebius Group Buyers Were Betting OnYahoo Finance · Nov 10, 2026Analysts are cautious on Lucid Group after earningsSeeking Alpha · Nov 10, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
73Pass
Philip Fisher
35No pass
Peter Lynch
29No pass
Joel Greenblatt
0No pass
Charlie Munger
35No pass
Terry Smith
36No pass
Questions about BGM Group
Is BGM Group a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BGM Group AI analysis
What does BGM Group do?
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. It is in Drug Manufacturers - Specialty & Generic.
Does BGM Group pay a dividend?
No. BGM Group does not pay a dividend at the moment.
Is BGM Group stock halal?
Yes. BGM Group passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
How has BGM Group stock done over the past year?
Down 97.3% over the past twelve months, to $7.70. It traded between $7.20 and $287.10 and is 97.3% below its high.
Who are BGM Group's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with BGM Group's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.